What Saphnelo treats
Saphnelo (anifrolumab) is a biologic medication used to treat moderate to severe systemic lupus erythematosus (SLE), a chronic autoimmune disease characterized by widespread inflammation and tissue damage. Saphnelo works by targeting and inhibiting type I interferon receptors, which play a key role in the inflammatory process of SLE.
Benefits of Saphnelo
Patients using Saphnelo often experience significant benefits, including reduced disease activity, fewer disease flares, and improved management of symptoms such as joint pain, skin rashes, and fatigue. By targeting specific inflammatory pathways, Saphnelo helps to achieve better disease control and improve quality of life for those with severe SLE. The regular infusion schedule allows for ongoing monitoring and adjustment of therapy based on patient response.
Possible Side Effects of Saphnelo
While Saphnelo is generally well-tolerated, some patients may experience side effects, including infusion-related reactions such as fever, chills, and rash. Other potential side effects include headache, nausea, and upper respiratory infections. Serious side effects, although rare, can include increased risk of infections and allergic reactions. It is important to monitor for any adverse effects and report them to your healthcare provider.
How infusion works at Prime
Saphnelo is administered at our infusion centers across New York and Atlanta. Our dedicated care team coordinates every step of your treatment with your prescribing physician.
Getting started
Patients: if you have a referral for Saphnelo, send us an inquiry using the form below and our care team will take it from there. Physicians: referring a patient to Prime Infusions is simple — just complete and fax or email the referral form above.
Ready to start?
For a medical emergency, call 911.
Our Infusion Centers
FAQ
Frequently asked questions
How Does Saphnelo Work?
Saphnelo works by binding to and inhibiting the type I interferon receptor, which is involved in the immune system’s inflammatory response in systemic lupus erythematosus. By blocking the activity of type I interferons, Saphnelo helps to reduce the inflammatory processes that contribute to SLE symptoms and disease progression. Saphnelo is administered through intravenous infusion, typically every four weeks.
Who is Saphnelo For?
Saphnelo is suitable for adults with moderate to severe systemic lupus erythematosus who have not achieved adequate disease control with standard treatments. It is recommended for individuals who experience persistent symptoms and require targeted therapy to manage their condition. Saphnelo is used in combination with standard lupus therapies to enhance disease management and improve overall outcomes.